Daye key facts
as of Oct 2026- Operator of a gynecological health company intended for women's health and well-being.
- Daye is valued at approximately $42.3M as of Oct 2026 (last reported valuation).
- It has raised $32.6M; the latest was Later Stage VC ($2.3M) in Nov 2025.
- Notable investors include European Innovation Council, Khosla Ventures, Gaingels, Index Ventures, Salica Investments — 27 tracked in total.
- Status: Privately Held (backing).
Daye's last reported valuation, Aug 2022. Nothing priced has surfaced since.
- ·The complete investor list: 27 names
- ·Watch Daye: the Monday email on marks, rounds and moves
Daye funding rounds
No funding rounds for Daye are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Daye
27+Daye valuation
Daye's last reported valuation was $42.3 million in Aug 2022. No priced round, secondary trade or fund mark has surfaced since.
Daye investors
27 investors are on record for Daye, including European Innovation Council, Khosla Ventures, Gaingels and Index Ventures. By type, the record holds 6 venture capital firms and 1 private investor.
About Daye
Operator of a gynecological health company intended for women's health and well-being. The company addresses the most prevalent, yet often overlooked, health conditions, from period and pelvic pain to cervical cancer prevention, enabling women to manage their gynecological health conveniently.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2017
- Employees
- 38
- Website
- yourdaye.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.